Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers

• Status: Completed
• Trial end date: 2015-08-01

Summary

A Clinical Trial to Demonstrate the Comparability of the Two Iron Sucrose Injection Solutions Iron Sucrose Azad of Azad Pharma AG and Venofer® of Vifor Pharma AG. The Hypothesis is That Both Iron Sucrose Injection Solutions Reveal the Same Active Substance Availability in the Blood Circuit.

• Phase: Phase 1

Details

• Lead Sponsor: Azad Pharma AG
• Treatments: Ferric Compounds; Ferric Oxide, Saccharated; Iron; Pharmaceutical Solutions